Clinical Trial: Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus.
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: SLE (Systemic Lupus)
Study Type: INTERVENTIONAL
Official Title: Safety/Phase I Study of PiggyBac Transposon Mediated Chimeric Antigen Receptor T Cells Targeting CD-19 in Thai Patients With Refractory Systemic Lupus Erythematosus
Brief Summary:
A Phase 1 clinical trial to evaluate the safety and efficacy of PiggyBac transposon-mediated Chimeric Antigen Receptor(CAR) T-cells targeting CD19 in refractory Systemic Lupus Erythematosus (SLE) patients who have not responded to standard immunosuppressive treatments.
Read more